Filing Details
- Accession Number:
- 0001209191-14-027247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-14 12:10:28
- Reporting Period:
- 2014-04-10
- Filing Date:
- 2014-04-14
- Accepted Time:
- 2014-04-14 12:10:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1417977 | C Leonard Debenedictis | 4698 Willow Road Pleasanton CA 94588 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-10 | 2,500 | $6.50 | 71,393 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-10 | 2,500 | $18.78 | 68,893 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-04-10 | 7,571 | $18.56 | 7,572 | No | 4 | S | Indirect | LEN C. DEBENEDICTIS TTEE LEN C. DEBENEDICTIS CHARITABLE REM. UNITRUST U/A DTD 08/03/1995 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | LEN C. DEBENEDICTIS TTEE LEN C. DEBENEDICTIS CHARITABLE REM. UNITRUST U/A DTD 08/03/1995 |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-04-10 | 2,500 | $0.00 | 2,500 | $6.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
127,500 | 2022-10-07 | No | 4 | M | Direct |
Footnotes
- The sales reported in this FORM 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 18, 2014.
- 25% of the total number of shares subject to the option vest on February 21, 2015, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer.